Lepu Medical Technology (Beijing) Co., Ltd. (SHE:300003)
China
· Delayed Price · Currency is CNY 11.24
-0.01 (-0.09%)
Apr 24, 2025, 2:45 PM CST
SHE:300003 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Mar '25 Mar 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Operating Revenue | 5,873 | 6,059 | 7,916 | 10,553 | 10,613 | 7,992 | Upgrade
|
| Other Revenue | 44.2 | 44.2 | 64.24 | 56.93 | 46.74 | 46.61 | Upgrade
|
| Revenue | 5,917 | 6,103 | 7,980 | 10,609 | 10,660 | 8,039 | Upgrade
|
| Revenue Growth (YoY) | -20.73% | -23.52% | -24.79% | -0.47% | 32.61% | 3.12% | Upgrade
|
| Cost of Revenue | 2,544 | 2,556 | 2,982 | 4,021 | 4,166 | 2,660 | Upgrade
|
| Gross Profit | 3,374 | 3,547 | 4,998 | 6,588 | 6,494 | 5,378 | Upgrade
|
| Selling, General & Admin | 2,196 | 2,236 | 2,440 | 2,776 | 2,858 | 2,445 | Upgrade
|
| Research & Development | 775.5 | 769.56 | 879.42 | 957.06 | 907.94 | 736.13 | Upgrade
|
| Other Operating Expenses | 31.35 | 63.28 | 58.37 | 33.9 | 103.14 | 82.56 | Upgrade
|
| Operating Expenses | 3,073 | 3,119 | 3,404 | 3,793 | 3,882 | 3,303 | Upgrade
|
| Operating Income | 300.09 | 427.99 | 1,594 | 2,795 | 2,612 | 2,076 | Upgrade
|
| Interest Expense | -183.53 | -181 | -170.65 | -188.78 | -228.49 | -268.92 | Upgrade
|
| Interest & Investment Income | 127.55 | 115.51 | 115.34 | 87.99 | 57.59 | 43.16 | Upgrade
|
| Currency Exchange Gain (Loss) | 26.91 | 26.91 | -25.38 | 16.14 | 6.58 | -26.96 | Upgrade
|
| Other Non Operating Income (Expenses) | -33.24 | -9.43 | -4.22 | -25.77 | -79.03 | -23.96 | Upgrade
|
| EBT Excluding Unusual Items | 237.8 | 379.99 | 1,509 | 2,684 | 2,368 | 1,799 | Upgrade
|
| Impairment of Goodwill | -62.95 | -62.95 | -33.45 | - | - | - | Upgrade
|
| Gain (Loss) on Sale of Investments | -87.51 | -89.32 | -13.44 | -70.91 | -367.54 | 298.06 | Upgrade
|
| Gain (Loss) on Sale of Assets | 11.75 | 11.73 | -4.07 | 0.02 | 19.9 | 2.29 | Upgrade
|
| Asset Writedown | -67.45 | -65.5 | -6.93 | -1.72 | -2.39 | -16.99 | Upgrade
|
| Other Unusual Items | 51.81 | 51.81 | 103.55 | - | 127.71 | 121.03 | Upgrade
|
| Pretax Income | 83.45 | 225.76 | 1,554 | 2,612 | 2,146 | 2,203 | Upgrade
|
| Income Tax Expense | 1.71 | 28.47 | 262.15 | 365.73 | 365.73 | 326.23 | Upgrade
|
| Earnings From Continuing Operations | 81.75 | 197.29 | 1,292 | 2,246 | 1,780 | 1,877 | Upgrade
|
| Minority Interest in Earnings | 61.86 | 49.64 | -34.15 | -42.28 | -61.09 | -75.15 | Upgrade
|
| Net Income | 143.61 | 246.94 | 1,258 | 2,204 | 1,719 | 1,802 | Upgrade
|
| Net Income to Common | 143.61 | 246.94 | 1,258 | 2,204 | 1,719 | 1,802 | Upgrade
|
| Net Income Growth | -87.44% | -80.37% | -42.91% | 28.18% | -4.58% | 4.44% | Upgrade
|
| Shares Outstanding (Basic) | 1,845 | 1,848 | 1,862 | 1,802 | 1,792 | 1,777 | Upgrade
|
| Shares Outstanding (Diluted) | 1,845 | 1,848 | 1,862 | 1,817 | 1,808 | 1,777 | Upgrade
|
| Shares Change (YoY) | -0.86% | -0.74% | 2.48% | 0.50% | 1.75% | 0.37% | Upgrade
|
| EPS (Basic) | 0.08 | 0.13 | 0.68 | 1.22 | 0.96 | 1.01 | Upgrade
|
| EPS (Diluted) | 0.08 | 0.13 | 0.68 | 1.21 | 0.95 | 1.01 | Upgrade
|
| EPS Growth | -87.33% | -80.23% | -44.29% | 27.54% | -6.22% | 4.05% | Upgrade
|
| Free Cash Flow | 365.91 | 75.82 | 145.69 | 1,885 | 2,078 | 1,490 | Upgrade
|
| Free Cash Flow Per Share | 0.20 | 0.04 | 0.08 | 1.04 | 1.15 | 0.84 | Upgrade
|
| Dividend Per Share | 0.277 | 0.277 | 0.331 | 0.341 | 0.275 | 0.228 | Upgrade
|
| Dividend Growth | -16.42% | -16.42% | -2.81% | 24.00% | 20.61% | 14.00% | Upgrade
|
| Gross Margin | 57.01% | 58.12% | 62.63% | 62.10% | 60.92% | 66.91% | Upgrade
|
| Operating Margin | 5.07% | 7.01% | 19.97% | 26.34% | 24.50% | 25.82% | Upgrade
|
| Profit Margin | 2.43% | 4.05% | 15.77% | 20.77% | 16.13% | 22.42% | Upgrade
|
| Free Cash Flow Margin | 6.18% | 1.24% | 1.83% | 17.77% | 19.49% | 18.53% | Upgrade
|
| EBITDA | 812.24 | 927.05 | 2,040 | 3,205 | 3,004 | 2,464 | Upgrade
|
| EBITDA Margin | 13.73% | 15.19% | 25.57% | 30.21% | 28.18% | 30.65% | Upgrade
|
| D&A For EBITDA | 512.14 | 499.06 | 446.75 | 410.11 | 392.37 | 388.21 | Upgrade
|
| EBIT | 300.09 | 427.99 | 1,594 | 2,795 | 2,612 | 2,076 | Upgrade
|
| EBIT Margin | 5.07% | 7.01% | 19.97% | 26.34% | 24.50% | 25.82% | Upgrade
|
| Effective Tax Rate | 2.04% | 12.61% | 16.86% | 14.00% | 17.04% | 14.81% | Upgrade
|
| Revenue as Reported | 5,917 | 6,103 | 7,980 | 10,609 | 10,660 | 8,039 | Upgrade
|
| Advertising Expenses | - | 28.49 | 84.23 | 60.08 | 76.04 | 76.08 | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.